Community
London, Ontario, Canada
NCT Number: NCT03254381
Older adults with type 2 diabetes experience cognitive decline and are at higher risk for developing dementia. Consequently, older adults at-risk for developing type 2 diabetes (based on body mass, glucose levels) are at higher risk for cognitive decline, and intervening at this point may prevent or delay the onset of such decline. One promising lifestyle intervention that has been shown to improve cognitive function in other populations is exercise. However, before investigators can examine whether exercise will improve cognitive function and brain health (structure and function) in this at-risk population, a feasibility pilot study is needed to determine whether a larger-scale trial would be viable.
Looking for future studies?
Notify Me60 year–80 year
All sexes
Interventional
Not applicable
London, Ontario, Canada
Investigators will conduct a six-month randomized control trial (RCT) exercise intervention. Thirty older adults (aged 60-80) at-risk for diabetes will be randomly assigned into one of two groups: 1) Resistance training, or 2) Balance and Tone training (control). All participants will engage in three one-hour exercise classes per week. Once a month, a neutral assessor will visit the classes to evaluate the quality of the classes for participants. Assessments will be made at baseline, midpoint (three months) and trial completion (six months), and will include cognitive testing, health questionnaires, physical testing, and magnetic resonance imaging (MRI; to assess structural and functional brain changes). Throughout the study, investigators will examine data for trends in successful recruitment strategies and rates of recruitment and adherence to inform future clinical trials in this population. Research assistants (n = 30) in the study will complete an anonymous feedback survey upon completion of their volunteer term, to assist in improving the study for future participants and volunteers.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Six months of thrice-weekly resistance training that will gradually progress in intensity. Each training session will be 60 minutes (10 minutes of warm-up, 40 minutes of training, and 10 minutes of cool-down). Classes will be group classes, with up to five participants in each.
Six months of thrice-weekly stretching and relaxation exercises. Each session will be 60 minutes. Classes will be group classes, with up to five participants in each.
Time frame: 12 months
Time frame: 6 months
Time frame: Baseline, 3 months, and 6 months
Time frame: Baseline and 6 months
Time frame: Baseline and 6 months
For this task, participants will be asked to encode and then recall items (face or places) and items in conjunction (faces matched with places)
Time frame: Baseline, 3 months, and 6 months
Time frame: Baseline, 3 months, and 6 months
Time frame: Baseline, 3 months, and 6 months
Time frame: Baseline, 3 months, and 6 months
Time frame: Baseline, 3 months, and 6 months
Time frame: Baseline, 3 months, and 6 months
Western University, Canada
Other
The Effect of Resistance Training on Cognitive Function and Brain Health in Older Adults At-risk for Diabetes: A Feasibility Pilot Study
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06150339
Behavior, Brain Diseases
Pickering, Ontario, Canada
View Trial DetailsNCT05658328
Behavior, Behavioral Symptoms
Portland, Oregon, United States
View Trial DetailsNCT05367076
Behavior, Cognition Disorders
Toronto, Ontario, Canada
View Trial DetailsNCT04212442
Behavior, Brain Diseases
Camden, New Jersey, United States
View Trial Details